More people around the world have nontuberculous mycobacteria (NTM) infections now than in the past. The infection most often comes from a type of NTM known as mycobacterium avium complex (MAC). MAC ...

An Australian study has linked rapidly growing mycobacterium infections to gastric banding surgery, but no clear source has been identified, according to an article published online September 10 in ...

The number of reported cases using viruses to treat deadly Mycobacterium infections just went up by a factor of five. Researchers report 20 new case studies on the use of the experimental treatment, ...

There’s exciting news in the world of phage therapy and antimicrobial resistance! Jerry Nick, MD, of National Jewish Health, and Graham Hatfull, PhD, University of Pittsburgh, announced a patient’s ...

A team of United States-based scientists recently conducted a study to evaluate the effect of Mycobacterium tuberculosis infection on the pathogenesis of severe acute respiratory syndrome coronavirus ...

Mycobacterium avium complex (MAC), a type of nontuberculous mycobacteria (NTM), lives all around us. You’ll find these germs in dirt, dust, and drinking water. They’re also common in natural sources ...

Accurate detection is essential to prevent misdiagnosis and ensure the right treatment, particularly in cases involving drug-resistant TB or NTM infections. The Hi-PCR ® MTB/NTM Probe PCR Kit offers a ...

Mycobacteria are a group of pathogenic bacteria that cause diseases like leprosy and tuberculosis in humans. Now, a new study finds that mycobacteria are associated with red blood cells at lung ...

The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired functionality—following the international gold standard for treating people with latent ...

Mycobacteria are a group of microorganisms with defined characteristics, widely distributed in various environments, including water and soil. They can be classified into mycobacteria causing ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...